| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |